Sodium Zirconium Cyclosilicate (Lokelma)
โก Sodium zirconium cyclosilicate (SZC) is a highly selective cation exchanger in the gastrointestinal tract.
It is licensed for the management of acute hyperkalaemia.
Always check the BNF here for up-to-date prescribing advice.
โน๏ธ About
- ๐ Prescribing advice must be checked in the BNF or local guidelines
- ๐ Brand name: Lokelma
- ๐งช Developed as a safer alternative to sodium polystyrene sulfonate (Resonium)
โ๏ธ Mode of Action
- ๐ก Non-absorbed, inorganic cation-exchange compound
- ๐ Selectively binds potassium in the gastrointestinal tract โ increases faecal excretion
- โ๏ธ Minimal absorption โ systemic side effects are rare
๐ Indication / Dose
- Used for the treatment of hyperkalaemia (both acute and maintenance)
๐ Dose Range (Always confirm with BNF / datasheet)
| Name | Starting Dose | Frequency | Route |
| Lokelma (initial) | 10 g | 3 times daily, for up to 72 hours | PO |
| Lokelma (maintenance) | 5โ10 g | Once daily or alternate days | PO |
๐ Interactions
- โ ๏ธ Can reduce absorption of other oral medicines (binds non-selectively) โ separate by at least 2 hours before or after
- Particular caution with immunosuppressants (e.g. tacrolimus, ciclosporin)
โ ๏ธ Cautions
- ๐ Risk of sodium and fluid overload โ monitor in patients with heart failure or CKD
- ๐ง Caution in patients at risk of oedema
- ๐งช Monitor potassium closely to avoid hypokalaemia
๐ซ Contraindications
- โ Severe constipation, bowel obstruction or impaction
- โ Known hypersensitivity to the drug or excipients
โก Side Effects
- ๐ Fluid retention, peripheral oedema
- โ๏ธ Hypokalaemia if overdosed
- ๐ฝ Gastrointestinal: constipation, mild diarrhoea
๐ References
๐ Revisions
- Content expanded with interactions, cautions, contraindications (Aug 2025)